Synapse - Elisa De Stanchina

Results (27)

RRAS and RRAS2 hotspot mutations as novel actionable oncogenic drivers in lung adenocarcinoma

Meeting Abstract

Ladanyi, M.; Yang, S. R.; Zhang, T.; de Stanchina, E.; Somwar, R.
Journal of Thoracic Oncology (2025)

Lurbinectedin synergizes with selinexor by inhibiting DNA damage repair and enhancing immune cell infiltration in neuroendocrine lung tumors

Meeting Abstract

Redin, E.; Manoj, P.; Qiu, J.; Zhong, H.; Vural, S.; Zhan, Y.; Koche, R.; Socci, N.; DeStanchina, E.; Rudin, C. M.; more...
Journal of Thoracic Oncology (2024)

Fulltext@MSK | Save

SMARCA4 controls state plasticity in SCLC through regulation of neuroendocrine transcription factors and REST splicing

Meeting Abstract

Redin, E.; Sridhar, H.; Zhan, Y.; Pereira Mello, B.; Zhong, H.; Manoj, P.; Linkov, I.; Qiu, J.; Koche, R. P.; de Stanchina, E.; more...
Journal of Thoracic Oncology (2024)

Fulltext@MSK | Save

Targeting TROP-2 in diffuse pleural mesothelioma

Meeting Abstract

Offin, M. D.; Tischfield, S.; Manoj, P.; Agrawal, P.; Tendler, S.; Pratt, E. C.; Travis, W.; Rimner, A.; Simone, C. B.; de Stanchina, E.; more...
Journal of Thoracic Oncology (2024)

Fulltext@MSK | Save

Tumor adaptation to PI3K inhibition and its stability increases as a function of time and is overcome by combined inhibiting Bcl2 family proteins

Meeting Abstract

Mukherjee, R.; Vanaja, K. G.; Sharma, M.; Solomon, H.; De Stanchina, E.; Chandarlapaty, S.; Rosen, N.
European Journal of Cancer (2024)

Fulltext@MSK | Save

Fully human monoclonal antibody targeting the cysteine-rich substrate-interacting region of ADAM17 on cancer cells

Journal Article

Saha, N.; Lee, S. G.; Brockmann, E. C.; de la Cruz, M. J.; Goldgur, Y.; Mendoza, R. P.; de Stanchina, E.; Love, T. M.; Marvald, J.; Xu, Y.; more...
Biomedicine and Pharmacotherapy (2024)

Fulltext@MSK | Save

Combination therapy with MDM2 and MEK inhibitors is effective in patient-derived models of lung adenocarcinoma with concurrent oncogenic drivers and MDM2 amplification

Journal Article

Elkrief, A.; Odintsov, I.; Markov, V.; Caeser, R.; Sobczuk, P.; Tischfield, S. E.; Bhanot, U.; Vanderbilt, C. M.; Cheng, E. H.; Drilon, A.; more...
Journal of Thoracic Oncology (2023)

Fulltext@MSK | Save

Targeting NFE2L2/KEAP1 mutations in advanced NSCLC with the TORC1/2 inhibitor TAK-228

Journal Article

Paik, P. K.; Fan, P. D.; Qeriqi, B.; Namakydoust, A.; Daly, B.; Ahn, L.; Kim, R.; Plodkowski, A.; Ni, A.; Chang, J.; more...
Journal of Thoracic Oncology (2023)

Fulltext@MSK | Save

Fully human monoclonal antibody targeting activated ADAM10 on colorectal cancer cells

Journal Article

Saha, N.; Baek, D. S.; Mendoza, R. P.; Robev, D.; Xu, Y.; Goldgur, Y.; De La Cruz, M. J.; de Stanchina, E.; Janes, P. W.; Xu, K.; more...
Biomedicine and Pharmacotherapy (2023)

Fulltext@MSK | Save

Vepafestinib is effective in preclinical models of sarcomas with RET fusion including a brain metastasis model

Meeting Abstract

Odintsov, I.; Liu, A.; Khodos, I.; Chang, Q.; Giuliano, C.; Mattar, M.; Vojnic, M.; Bonifacio, A.; De Stanchina, E.; Lovati, E.; more...
European Journal of Cancer (2022)

Fulltext@MSK | Save